NM_004333.6(BRAF):c.915G>A (p.Ala305=) AND not provided

Germline classification:: Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:: Mar 18, 2023
Review status:: criteria provided, conflicting classifications

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003136071.4

Allele description [Variation Report for NM_004333.6(BRAF):c.915G>A (p.Ala305=)]

NM_004333.6(BRAF):c.915G>A (p.Ala305=)

Gene:

BRAF:B-Raf proto-oncogene, serine/threonine kinase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7q34

Genomic location:

Preferred name:

NM_004333.6(BRAF):c.915G>A (p.Ala305=)

HGVS:

NC_000007.14:g.140800427C>T
NG_007873.3:g.129338G>A
NM_001354609.2:c.915G>A
NM_001374244.1:c.915G>A
NM_001374258.1:c.915G>A
NM_001378467.1:c.924G>A
NM_001378468.1:c.915G>A
NM_001378469.1:c.915G>A
NM_001378470.1:c.813G>A
NM_001378471.1:c.915G>A
NM_001378472.1:c.759G>A
NM_001378473.1:c.759G>A
NM_001378474.1:c.915G>A
NM_001378475.1:c.651G>A
NM_004333.6:c.915G>AMANE SELECT
NP_001341538.1:p.Ala305=
NP_001361173.1:p.Ala305=
NP_001361187.1:p.Ala305=
NP_001365396.1:p.Ala308=
NP_001365397.1:p.Ala305=
NP_001365398.1:p.Ala305=
NP_001365399.1:p.Ala271=
NP_001365400.1:p.Ala305=
NP_001365401.1:p.Ala253=
NP_001365402.1:p.Ala253=
NP_001365403.1:p.Ala305=
NP_001365404.1:p.Ala217=
NP_004324.2:p.Ala305=
LRG_299t1:c.915G>A
LRG_299:g.129338G>A
NC_000007.13:g.140500227C>T
NM_004333.4:c.915G>A
NM_004333.6:c.915G>A

Links:

dbSNP: rs145675911

NCBI 1000 Genomes Browser:

rs145675911

Molecular consequence:

NM_001354609.2:c.915G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001374244.1:c.915G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001374258.1:c.915G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001378467.1:c.924G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001378468.1:c.915G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001378469.1:c.915G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001378470.1:c.813G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001378471.1:c.915G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001378472.1:c.759G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001378473.1:c.759G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001378474.1:c.915G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001378475.1:c.651G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_004333.6:c.915G>A - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003828533	Revvity Omics, Revvity	criteria provided, single submitter (ACMG Guidelines, 2015)	Uncertain significance (Mar 1, 2020)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV004563397	ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories	criteria provided, single submitter (ARUP Molecular Germline Variant Investigation Process 2024)	Likely benign (Mar 18, 2023)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003828533

Revvity Omics, Revvity

criteria provided, single submitter

(ACMG Guidelines, 2015)

Uncertain significance
(Mar 1, 2020)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004563397

ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories

criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process 2024)

Likely benign
(Mar 18, 2023)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Revvity Omics, Revvity, SCV003828533.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV004563397.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine